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ABSTRACT 
 
Background: Vanadium is an essential transition metal in biological systems. Several key proteins 
related to vanadium accumulation and its physiological function have been isolated, but no vanadium 
ion transporter has yet been identified.  
Methods: We identified and cloned a member of the Nramp/DCT family of membrane metal transporters 
(AsNramp) from the ascidian Ascidia sydneiensis samea, which can accumulate extremely high levels of 
vanadium in the vacuoles of a type of blood cell called signet ring cells (also called vanadocytes). We 
performed immunological and biochemical experiments to examine its expression and transport 
function. 
Results: Western blotting analysis showed that AsNramp was localized at the vacuolar membrane of 
vanadocytes. Using the Xenopus oocyte expression system, we showed that AsNramp transported VO2+ 
into the oocyte as pH-dependent manner above pH 6, while no significant activity was observed below 
pH 6. Kinetic parameters (Km and Vmax) of AsNramp-mediated VO2+ transport at pH 8.5 were 90 nM and 
9.1 pmol/oocyte/h, respectively. A rat homolog, DCT1, did not transport VO2+ under the same conditions. 
Excess Fe2+, Cu2+, Mn2+ or Zn2+ inhibited the transport of VO2+.  
Conclusions: AsNramp was revealed to be a novel VO2+/H+ antiporter, and we propose that AsNramp 
mediates vanadium accumulation coupled with the electrochemical gradient generated by vacuolar 
H+-ATPase in vanadocytes. 
General Significance: This is the first report of identification and functional analysis on a membrane 
transporter for vanadium ions. 
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1. Introduction 
 
     Some ascidians, known as tunicates or sea squirts, belonging to the suborder Phlebobranchia 
(Chordata, Urochordata, Ascidiacea), accumulate extremely high levels of vanadium in vanadocytes, 
one of their approximately ten types of blood cell [1-4]. The vanadium concentration in vanadocytes can 
reach 350 mM [5, 6], corresponding to 107 times the level in seawater (35 nM). This is thought to be the 
highest rate of accumulation of a metal in any living organism.  
     In the sea water, vanadium is dissolved in the +5 oxidation state (HVO43– or H2VO42–; VV). During 
the accumulation process, VV is reduced to the +3 oxidation state (V3+; VIII) via the +4 oxidation state 
(VO2+; VIV) [7]. NADPH is a strong candidate to participate in the reduction of VV to VIV, as the 
enzymes involved in the pentose phosphate pathway are expressed exclusively in the cytoplasm of 
vanadocytes [8-11], and detailed in vitro studies have suggested that this reaction occurs with the 
assistance of several chelating substances [12, 13]. Vanabins, which are named as vanadium-binding 
proteins, isolated from the cytoplasm of vanadocytes as well as blood plasma are capable of binding as 
many as ca. 10–20 VIV ions per molecule of protein, and are thought to play an important role in 
VV-reduction, VIV-transport, and VIV-storage processes in the cytoplasm of vanadocytes [14-19].  
     The content of the vanadocyte vacuole is maintained at an extremely low pH reaching 1.9, and the 
concentration of vanadium is correlated with that of protons [5]. As vacuolar-type H+-ATPase 
(V-ATPase) is localized on the vacuolar membrane of vanadocytes and V-ATPase maintains low pH in 
the vacuole of vanadocytes [20-22], we hypothesized that a proton gradient generated by V-ATPase 
provides the energy to transport vanadium across the vacuolar membrane. To assess this hypothesis, we 
first cloned a cDNA encoding a member of the Nramp (natural resistance-associated macrophage 
protein)/DCT1 family from vanadocytes of Ascidia sydneiensis samea because the Nramp/DCT1 family 
is known to transport a broad range of divalent cations (Fe2+, Cu2+, Zn2+, Mn2+, Cd2+, Co2+, Ni2+, and 
Pb2+) across the membrane using a proton gradient as the motive force [23, 24]. We showed that the 
product of this gene, AsNramp, is localized on the vacuolar membrane and can operate as an antiporter 
of VIV and H+. 
 
2. Materials and methods 
 
2.1.Animals 
 
     Adults of the ascidian A. sydneiensis samea were collected at Yamada Bay, Iwate, Japan. Blood 
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was extracted and diluted with Ca2+, Mg2+-free artificial sea water (460 mM NaCl, 9 mM KCl, 32 mM 
Na2SO4, 6 mM NaHCO3, 5 mM HEPES, and 5 mM EDTA, pH 7.0). Blood cells were collected by 
centrifugation at 300 × g for 10 min at 4°C. Giant cells were removed by sucrose density gradient 
centrifugation, as this type of cell contains highly acidic materials that adversely affect protein and RNA 
extraction. 
 
2.2. Molecular Cloning of the AsNramp Gene 
 
     We designed four degenerate primers from the conserved regions of known Nramp/DCT1 family 
metal transporter genes, DCT1AS1f: 5'-TTY WSN YTN MGN AAR YTN TGG GC-3', DCT1AS2f: 
5'-TTY ACN GGN CCN GGN TTY YTN ATG-3', DCT1AS3r: 5'-GTD ATN ARN ACN CCN CCC 
CA-3', and DCT1AS4r: 5'-TGN CCN GCR TAN GTN CCN GTC AT-3'. RNAs were extracted from A. 
sydneiensis samea blood cells and cDNAs were synthesized from total RNA as previously [20]. The 
first-round PCR reaction was set up as follows: cDNAs corresponding to 150 ng of total RNAs, 200 
pmol of each of the primers DCT1AS1f and DCT1AS4r, each dNTP at 0.2 mM, 1× reaction buffer, and 
2.5 units of Taq DNA polymerase (TaKaRa, Inc.). The reaction volume was 50 µl After denaturation at 
94°C for 2 min; 30 cycles of PCR were performed (94°C for 60 s, 45°C for 60 s, and 72°C for 120 s) 
followed by a final extension at 72°C for 6 min. After the reaction, 1-µl aliquots of the first-round 
reaction mixture were taken as the template for the second-round reaction. The second-round reaction 
was performed using the same amounts of primers DCT1AS2f and DCT1AS3r as in the first reaction, 
and PCR cycles were the same as those in the first round. The PCR products were separated by agarose 
gel electrophoresis. The band of the expected size (~350 bp) was excised and cloned into the pBluescript 
vector and its nucleotide sequence was determined by the dideoxy method using an ALFexpress DNA 
sequencer and Thermo Sequenase kit (GE healthcare). A cDNA library of A. sydneiensis samea blood 
cells [9] was screened with the cDNA fragment. Positive phages were rescreened until they were cloned. 
The cDNAs were excised in vivo, subcloned into pBluescript, and sequenced. Representative cDNA 
clone #1171 was used for further analysis. Amino acid sequences were compared by the 
neighbor-joining method [25] using ClustalW [26]. 
 
2.3. Construction of Plasmids and In Vitro Synthesis of mRNAs for AsNramp and Rat DCT1 
 
     The coding region of AsNramp and rat DCT1 were amplified by Easy-A High-Fidelity PCR 
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cloning enzyme using specific primer sets with artificial restriction sites as follows: AsNramp-pHA-F1, 
5'-AGA TCT GGA ACC ATG TCC TCT AAA G-3' and AsNramp-pHA-R1, 5'-GGA TCC TTC GTT 
AAT ACA TTC ATT TTC-3' for AsNramp (this study), and rDCT1-pHA-F1, 5'-AGA TCT ACC ATG 
GTG TTG GAT CCT GAA G-3' and rDCT1-pHA-R1, 5'-CTC GAG CCT TAG TAT TGC CAC CGC 
TG-3' for rat DCT1 (based on GenBank AF008439). The amplified fragments were digested with BglII 
and XhoI and ligated into the corresponding site of the pT7G HA C expression vector [27]. The 
nucleotide sequence was confirmed by the DNA Sequencing Service at the Natural Science Center for 
Basic Research and Development, Hiroshima University. The resulting plasmids (pT7G-AsSUL1-HA 
and pT7G-DCT1-HA, 10 µg each) were linearized with NotI. After incubation with 100 µg/ml 
Proteinase K, 0.5% SDS, and 5 mM EDTA at 56°C for 30 min, proteins were removed successively with 
Tris-saturated phenol and phenol–chloroform. Plasmid DNA was precipitated with ethanol and dissolved 
in 10 µl of TE buffer. Synthesis of mRNA was performed using a mMESSAGE mMACHINE kit 
(Ambion Life Technologies). The DNA template (1.0 µg) was mixed with ribonucleotide mixture, 
transcription buffer, and enzyme mix in a total volume of 20 ml. The mixture was incubated at 37°C for 
3 h. Synthesized mRNAs were extracted with Tris-saturated phenol, phenol–chloroform, and chloroform 
successively, precipitated with ethanol, and dissolved in 13 µl of RNase-free water (~1 µg/ml). The 
actual concentration of mRNA was determined by spectrophotometry. 
 
2.4. Metal solution and reducing agents 
 
     Vanadyl sulfate (VOSO4, 99.5%,  Wako Pure Chemical Industries) was dissolved at 10 mM in 
ultrapure water just before use. Iron chloride (FeCl2), copper chloride, manganese chloride, zinc chloride 
and nickel chloride were also purchased from Wako, and were dissolved at 100 mM in ultrapure water. 
 
2.5. Transport Assay for AsSUL1 and Rat DCT1 in Xenopus Oocytes 
 
     Ovaries were excised from Xenopus laevis females and treated with collagenase as described 
previously [28]. Oocytes at stage V or VI were collected in MBS buffer (8.8 mM NaCl, 1 mM KCl, 2.4 
mM NaHCO3, 10 mM HEPES, 0.82 mM MgSO4·7H2O, 0.33 mM Ca(NO3)2·4H2O, 0.41 mM 
CaCl·2H2O), and synthetic mRNA was injected into each oocyte using a NANOJECT instrument 
(Drummond Scientific Co.). Oocytes were incubated at 18°C in MBS buffer supplemented with 
penicillin (10 U/ml) and streptomycin (10 µg/ml).  
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     Uptake experiments were performed 4 days after injection of synthetic mRNAs. Uptake solution 
contained 100 mM NaCl or choline-Cl, 10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM CaCl2, and 1 
mM MgCl2, and the pH was adjusted by adding MES to pH 4.5 or 5.5 or Tris to pH 6.5, 7.5 and 8.5. 
Oocytes were settled at 20°C in fresh MBS buffer for at least 30 min before uptake experiments. They 
were then incubated in uptake solution containing appropriate concentrations of VOSO4. In inhibition 
experiments, 50 molar excess of appropriate divalent cations were added together. When using iron 
chloride (FeCl2), ascorbic acid was used at 4 molar excess to maintain reduced state of FeII. After 
incubation for appropriate times at 20°C, oocytes were washed five times with ice-cold uptake buffer 
without adding vanadium, and oocytes were put in separate tubes and homogenized in 1 N HNO3. Total 
concentration of vanadium was determined by atomic absorption spectroscopy (AAS; Spectra AA-220Z; 
Varian Inc.). 
 
2.6. Western blotting 
 
     Western blotting was performed to examine the expression of injected mRNAs in Xenopus 
oocytes and the subcellular localization of AsNramp in blood cells. 
     Oocytes were frozen in liquid nitrogen and homogenized in EB plus buffer (80 mM 
β-glycophosphate, 15 mM MgCl2, 20 mM EGTA, pH 7.5) with protease inhibitors (2 mM PMSF, 0.1 
mM Pepstatin A, 30 µg/ml Leupeptin). The supernatant was obtained by centrifugation at 15,000 rpm 
for 10 min at 4°C and used for SDS-PAGE and Western blotting. Anti-HA antibody (HA124; Nacalai 
Tesque, Inc.) was used at 1:10,000 dilution to detect AsNramp protein. HRP-conjugated anti-mouse IgG 
antibodies (PI-2000; Vector, Inc.) were used and the signals were detected with Chemi-Lumi-One 
reagents (Nacalai Tesque, Inc.). 
     A synthetic polypeptide (CLSRLKSSFSRLNE) corresponding to the C-terminal hydrophilic 
domain of AsNramp was prepared and conjugated with keyhole limpet hemocyanin. Aliquots of 15 µg 
of the peptide were injected intraperitoneally into 8-week-old female BALB/c mice. The injection was 
repeated five times at 2-week intervals. Three days after the last injection, blood was collected, allowed 
to stand at 37°C for 1 h, and incubated at 4°C for 12 h. The serum was removed from the clot, and any 
remaining insoluble material was removed by centrifugation at 10,000 × g for 10 min at 4°C. The 
supernatant thus obtained was stored at –20°C and used as the anti-AsNramp antiserum. Fractionation of 
blood cell components and Western blotting were performed according to our previous report [29]. The 
antiserum was used for immunoblotting analysis and immunocytochemistry at 1:4000 and 1:1000 
 
7 
dilutions, respectively. The signals were detected as described for the anti-HA antibody.  
 
3. Results 
 
3.1. Cloning of an Ascidian Nramp Gene 
 
     We first amplified cDNA fragments related to an Nramp gene from the A. sydneiensis samea 
blood cell cDNA pool by nested PCR using two pairs of degenerate primers corresponding to conserved 
amino acid sequences of known Nramp family proteins. Using the PCR fragment as a probe, we then 
isolated a cDNA clone encoding a protein closely related to Nramp family proteins from the cDNA 
library of A. sydneiensis samea blood cells. This cDNA contained a single, long open reading frame of 
1761 nucleotides, including the stop codon, which encoded a protein of 586 amino acids. The amino 
acid sequence deduced from the cDNA clone showed striking similarities to Nramp proteins from 
various organisms. The alignment of amino acid sequences predicted by cDNA cloning and human 
Nramp1 and Nramp2, and rat DCT1 proteins are shown in Fig. 1. The amino acid sequence showed 
58.2%, 61.1% and 61.3% identity to human Nramp1 and Nramp2, and rat DCT1 sequences, respectively. 
The predicted amino acid sequence contained 12 putative transmembrane domains (TM1 – TM12) and a 
consensus transport motif (CTM), which exists in all Nramp family proteins. Therefore, we concluded 
that the cDNA clone corresponded to an Nramp homolog in A. sydneiensis samea, which we named 
AsNramp. Molecular phylogenetic analysis by the neighbor-joining method [25] did not significantly 
cluster this AsNramp homolog to either Nramp1 or Nramp2 group (Fig. 2). Another ascidian species 
Ciona intestinalis possess one ortholog of Nramp (CiCLSTR12032), which is clustered with AsNramp. 
No IRE-like sequence was found in its 3'-noncoding region. 
     Several amino acid residues had been revealed to be functionally important. For example, 
mutations in the first external loop (G119, D124, Q126 in rat DCT1) and E154 in TM3have been shown 
to affect uptake activity and specificity [30, 31]. Mutation in G216 in rat DCT1 (TM4) resulted in loss of 
iron uptake and caused anemia [32]. D117 (TM1), D223 (TM4) and E330 (TM7) in rat DCT1 have been 
revealed to be essential in yeast complementation assay. H267 and H272 (TM6) in rat DCT1 was 
identified to be important in pH regulation [33]. All of these essential residues were conserved in 
AsNramp (Fig. 1). Two potential N-glycosilation sites were also conserved, and it suggested that 
membrane topology is also conserved with other Nramps. 
 
3.2. Subcellular Localization of AsNramp 
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     In order to examine the sub-cellular localization of AsNramp within blood cells, we raised a 
polyclonal antibody against the C-terminal polypeptide of AsNramp. We performed Western blot 
analysis on blood cell homogenates fractionated by a stepwise centrifugal fractionation. The apparent 
molecular size of AsNramp was ca. 160 kDa (Fig. 3), which is higher than the calculated molecular 
weight (65.2 kDa). This could be due to glycosilation, as shown in oocyte experiments. V2C12 antibody 
[18] was used as a control for vacuolar localization. It detected a vacuolar membrane protein of ca. 130 
kDa (Fig. 3), which was segregated in the same fraction as AsNramp. These results suggested that 
AsNramp was localized on the vacuolar membrane of the blood cells. Since the pH of the vacuole is 
extremely low in vanadium-rich ascidians, we expected that AsNramp could act as proton-dependent 
vanadium transporter. 
 
3.3. Transport of VO2+ by AsNramp and Rat DCT1  
 
     No reports exist regarding the transport of vanadium by the Nramp/DCT1 family of metal 
transporters. We prepared Xenopus oocytes injected with AsNramp and rat DCT1 (rDCT1) for 
comparison. Non-injected eggs were used as controls. Expression of AsNramp and DCT1 was confirmed 
using anti-HA antibody (Fig. 4). The apparent sizes of AsNramp and rDCT1 ranged from 45 kDa to 
more than 100 kDa, while the predicted sizes were 65.2 and 61.3 kDa, respectively. Since treatment by 
trifluoromethanesulfonic acid (TFMS) decreased the extra bands (data not shown), this may have been 
due to glycosylation. 
     We first used an uptake buffer containing NaCl (100 mM NaCl, 10 mM HEPES, 2 mM MES, 2 
mM KCl, 1 mM CaCl2, and 1 mM MgCl2), and found that control oocytes showed uptake activity for 
VO2+, and the activity was higher at pH 5.5 than at pH 7.5 (Fig. 5A). Expression of AsNramp or rDCT1 
had no significant effect on this basal activity under these conditions. This result suggested that 
AsNramp and rDCT1 could not transport VO2+ in the presence of sodium ions. Therefore, we used 
choline-Cl in place of NaCl, since choline can be used to maintain the osmolarity of the uptake buffer 
but do not compete with metal ions. As a result, AsNramp caused significant uptake activity in a buffer 
containing choline-Cl at pH 7.5. In contrast, transport activity in AsNramp-injected at pH 5.5 was 
slightly higher than control oocytes but the difference was not significant. rDCT1 injection did not cause 
any significant change in VO2+ uptake activity under any conditions. Thus, AsNramp could act as a VO2+ 
transporter at pH 7.5 in the absence of NaCl. In contrast, rDCT1 could not transport VO2+ under any of 
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the conditions examined. 
     As the Nramp/DCT family of proteins are known to be pH-dependent divalent cation  
transporters, the pH dependency of VO2+ transport by AsNramp was examined in detail (Fig. 5B). 
Uptake activity of control oocytes was higher at low pH. At pH 4.5 and 5.5, no significant uptake by 
AsNramp was observed. At pH 6.5–8.5, AsNramp transported VO2+ into oocytes significantly. A 
protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) was used to confirm the 
relationship between VO2+-transport and pH gradient across the oocyte membrane. As shown in Fig. 5C, 
addition of FCCP at 2.5 µM in the uptake buffer at pH8.5 neutralized the AsNramp-mediated transport 
of VO2+. This experiment confirmed that VO2+-transport by AsNramp was coupled with H+.  
     The metal selectivity of AsNramp was assessed by adding excess concentration of metal ions in 
the transport assay (Fig. 6). In the presence of 50 molar excess of Cu2+, Mn2+ and Zn2+, VO2+-transport 
by AsNramp was significantly suppressed (p<0.01), and the effect of Mn2+ was most significant. For 
experiments using 50 molar excess of Fe2+, Ascorbic acid was used at 4 molar excess to maintain 
reduced state of Fe2+. In control experiment with ascorbic acid but without Fe2+, the uptake of VO2+ was 
reduced to about a half of control without ascorbic acid. The reason is unclear. When 50 molar excess of 
Fe2+ was added with ascorbic acid, the uptake of VO2+ was almost completely suppressed as compared 
to the control experiments with ascorbic acid but without Fe2+ (p<0.05). These results suggested that 
these divalent cations competed with VO2+. 
     Kinetic assay for VO2+ transport by AsNramp was performed by changing the concentration of 
vanadium in the medium. At lower concentrations (up to 10 µM), the uptake rate appeared as 
Michaelis–Menten kinetics, but the uptake rate decreased in the range higher than 10 µM VO2+ (Fig. 7). 
The kinetic parameters (Km and Vmax) of AsNramp-mediated VO2+ transport at pH 8.5 were calculated to 
be 90 nM and 9.1 pmol/oocyte/h, respectively, at concentrations of VO2+ up to 10 µM. 
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4. Discussion 
 
     In this study, we first isolated a homolog of the Nramp/DCT1 divalent cation transporter family 
from the blood cells of the vanadium-rich ascidian A. sydneiensis samea. As the Nramp/DCT family 
consists of structurally and functionally well conserved proteins found in bacteria, fungi, animals, and 
plants, we hypothesized that an Nramp/DCT1 homolog exists in ascidians and acts as a divalent cation 
transporter. The present study indicated that AsNramp is localized in the vacuolar membrane of 
vanadocytes and acts as a VO2+/H+ antiporter to accumulate vanadium in the vacuole using 
electrophysiological gradient of protons, which are accumulated by vacuolar-type H+-ATPases 
(V-ATPases). 
     The genomes of vertebrates possess two orthologs of the Nramp/DCT1 protein family in their 
genome. From two ascidians, A. sydneiensis samea and Ciona intestinalis, we identified only one 
ortholog in each species. Molecular phylogenetic analysis did not significantly cluster the AsNramp to 
either Nramp1 or Nramp2, while AsNramp and its homolog in C. intestinalis were clearly clustered (Fig. 
2). This suggested that gene duplication occurred in the ancestor of vertebrates. 
     Western blotting analysis using antiserum against AsNramp indicated that AsNramp is localized 
on the vacuolar membrane of blood cells in A. sydneiensis samea (Fig. 3). This is reminiscent of 
Nramp1 in humans and rodents. In mammals, Nramp1 is expressed predominantly in macrophages and 
monocytes, and regulates intracellular pathogen proliferation and inflammatory responses [34]. Tissue 
localization study indicated that Nramp1 is present in lysosomes/late endosomes in macrophages [35]. In 
contrast, Nramp2 is expressed in most tissues and acts as an iron uptake transporter operating at the 
endosome membrane with the transferrin system [36]. In addition to such ubiquitous expression and 
function, the expression of Nramp2 is highest at the brush border membrane of the intestine and acts as a 
transferrin-independent iron uptake transporter [37, 38]. It is necessary to examine in future study 
whether AsNramp also functions in the intestine or other tissues. 
     The direction of transport and metal selectivity is well studied for mammalian Nramps. Nramp2 is 
reported to be a symporter for proton/divalent cations that uses a proton electrochemical gradient as an 
energy source. Transport study using Xenopus oocytes or mammalian cell lines indicated that Nramp2 
transports a broad range of divalent cations, such as Fe2+, Zn2+, Cd2+, Mn2+, Cu2+, and Co2+, but not Ca2+ 
or Mg2+, in a pH-dependent manner [38]. In contrast, the direction of proton/metal transport by Nramp1 
is controversial. One study used Xenopus oocytes to examine the metal transport by Nramp1 and 
revealed that Nramp1 acts as an antiporter for proton and divalent cations Fe2+, Zn2+, and Mn2+ [39]. The 
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present study indicated that AsNramp acts as a proton/VO2+ antiporter (Fig. 5). We examined the effect 
of excess divalent ions on the transport of VO2+ and found that Fe2+, Cu2+, Mn2+ and Zn2+ inhibited at 
certain degrees (Fig. 6). This result suggested that AsNramp can also transport several divalent cations as 
the same manner. It is desirable to compare the structure of metal binding site(s), the site(s) to specify 
metal selectivity and proton coupling in AsNramp and other Nramps, but three dimensional structure of 
any Nramp proteins have not been determined yet. So far, spontaneous and artificial mutant studies in 
mammals and yeast suggested several amino acid residues that are important for metal transport and 
proton coupling, and at least the amino acid residues that are known to be important in mammals and 
yeast were conserved in AsNramp (Fig. 1). Further functional analysis should be performed to identify 
amino acid residues that are unique to AsNramp and responsible for VO2+ transport, or those common to 
human Nramp1 and AsNramp that could be responsible for antiport of protons and divalent cations. 
     Kinetic analysis of AsNramp indicated that the uptake rate appeared to fit Michaelis-Menten 
kinetics at low concentrations up to 10 µM VO2+ (Fig. 7). If we compare the Km value with those for 
other metals, the apparent Km for VO2+ obtained by AsNramp transport assay (90 nM) was one or several 
orders smaller than those obtained for Fe2+ (2.2 µM) [38, 40], Cd2+ (1.0 µM) [41], and Zn2+ (562 nM) 
[39]. This result suggested that AsNramp could act as a high-affinity VO2+ transporter. 
     Vanadium transport by Nramp has not been reported in any other organism. Since we found that 
rat DCT1 cannot transport VO2+ under the present assay conditions, the vanadium transport could be a 
unique feature of Nramp in vanadium-rich ascidians. It is necessary to examine other Nramp/DCT 
homologs from additional organisms including other vanadium-rich ascidians to examine whether they 
can transport vanadium or not. In addition, we found that Xenopus oocytes can accumulate VO2+ at low 
pH (Fig. 5A), which indicated that a proton/VO2+ symporter is expressed in the oocytes, although its 
identity is not clear. 
     When we consider the accumulation process, VV is a major chemical species in the external 
environment and probably in coelomic fluid, transported into the cytoplasm, and reduced to VIII via VIV 
[7]. A question remains regarding the identity of the transporter for VV. Phosphate transporter is a 
candidate transporter for VV (HVO43– or H2VO42–), the chemical features of which resemble those of 
phosphate anions (HPO43– or H2PO42–), and we are currently attempting to identify homologs of NaPi- or 
PiT-type phosphate transporters expressed in vanadocytes. Such anion transporters may also act in the 
first step of vanadium uptake in the branchial sac or the intestine. 
     In our model, VV is readily reduced to VIV and VIV is stabilized by Vanabins, which act as 
vanadium reductase and vanadium chaperone, in the cytoplasm (Fig. 8) [19, 42]. Then, VIV (VO2+) is 
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transported into the vacuole by a cation transporter, AsNramp, as suggested in the present study. The 
results of the present study indicated that AsNramp is a VO2+/H+ antiporter expressed on the vacuolar 
membrane of vanadocytes. These findings supported the proposed model that proton electrochemical 
gradient generated by V-ATPase is the driving force for VO2+ transport from the cytoplasm into the 
vacuole (Fig. 8). We reported previously that the vacuole of vanadocytes contains high concentrations of 
protons and sulfate ions [5, 43, 44]. V-ATPase is expressed on the vacuolar membrane of the 
vanadocytes [22] and a functional sulfate transporter AsSUL1 was isolated from vanadocytes [44]. Most 
of the vanadium ions that accumulate in the vanadocytes are in the +3 oxidation state (V3+; VIII) and are 
stably stored in the acidic vacuole, where sulfate ions act as counterions. 
     Several other pathways may exist that act together (Fig. 8). Another possible mechanism for VIV 
transport into the vacuole is driven by P1B-type ATPase, AsHMA1, which we have already cloned from 
blood cells of A. sydneiensis samea and examined its metal selectivity and transport activity (Ueki et al., 
unpublished data). In addition, some portion of vanadium is circulated as VIV in coelomic fluid and 
transported by a cation transporter on the plasma membrane of vanadocytes, as we have previously 
identified a vanadium-binding protein VanabinP that can bind and stabilize VIV in the coelomic fluid,  
     The accumulation, reduction, and transport of vanadium ions should be tightly linked. The 
analysis of vanadium transporters should provide more detailed information regarding the vanadium 
transport pathway that underlies the extraordinarily high level of vanadium accumulation in ascidians. 
The physiological function of accumulated vanadium ions in reduced forms, VIV or VIII, must be exerted 
through redox-coupled reactions. The study of vanadium assimilation in ascidians should also provide 
fundamental insight into the physiological roles of vanadium not only in ascidians but also in mammals, 
in which vanadium is an essential element. 
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Figure legends 
 
 
Fig. 1. Amino acid sequence alignment of an Nramp homolog of Ascidia sydneiensis samea (AsNramp), 
human Nramp1 (hNramp1), Nramp2 (hNramp2) and rat DCT1 (rDCT1). Identical amino acid residues 
are boxed. Twelve putative transmembrane domains are shaded (TM1 to TM12). Numbers indicate 
amino acid residues for each sequence. Open circles over each amino acid residue indicate identical ones 
that have been reported to be functionally essential or important. Asterisks indicate the position of 
possible N-glycosilation sites. Conserved transport motif is indicated by a double-headed arrow (CTM). 
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Fig. 2. Phylogenetic tree using the neighbor-joining method based on amino acid sequences of Nramp 
family proteins. Two ascidian species (AsNramp and CiCLSTR12032, from Ascidia sydneiensis samea 
and Ciona intestinalis, respectively) were compared with homologs from representative organisms 
Labels are taken from SwissProt database IDs (ECOLI, Escherichia coli; YEAST, Saccharomyces 
cerevisiae; ARATH, Arabidopsis thaliana; DROME, Drosphila melanogaster; CAEEL, Caenorhabditis 
elegans; HUMAN, Homo sapiens; RAT, Rattus norvegicus; MOUSE, Mus musculus). The scale bar 
indicates 0.1 amino acid substitutions per site. Numbers at each branch indicate the percentage of times 
that a node was supported in 1000 bootstrap pseudoreplicates. Note that two ascidian species were 
clearly clustered, but they were not significantly clustered to either Nramp1 or Nramp2. 
 
 
20 
 
Fig. 3. Expression of AsNramp protein identified by anti-AsNramp antiserum on a Western blot after 
fractionation. Samples were separated by 8% SDS-PAGE. After electrophoresis, the gels were 
transferred onto nitrocellulose membranes and reacted with 1:4000 dilution of anti-AsNramp antiserum. 
Lane 1, homogenate blood cells without giant cells; lane 2, pellet obtained by centrifugation at 1100 × g; 
lane 3, pellet obtained by centrifugation at 11,000 × g; lane 4, pellet obtained by centrifugation at 
100,000 × g; lane 5, soluble protein. V2C12 recognizes a 130-kDa vacuolar membrane protein. Note 
that an AsNramp signal (~160 kDa) was detected in the vacuolar membrane fraction (lane 4). 
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Fig. 4. Western blotting analysis of Xenopus oocytes injected with AsNramp or rat DCT1 mRNA. After 
SDS-PAGE, the gels were either stained with Coomassie Brilliant Blue (lanes 1–3), or the protein bands 
were transferred onto nitrocellulose membranes and probed with anti-HA antibody (lanes 4–6). Lanes 1 
and 4, extract from control Xenopus oocytes; lanes 2 and 5, extract from oocytes injected with AsNramp 
mRNA; lanes 3 and 6, extract from oocytes injected with rat DCT1 mRNA. Note the broad signal from 
45 kDa to more than 100 kDa detected only in oocytes injected with AsNramp or rat DCT1 mRNA 
(lanes 5 and 6). 
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Fig. 5. Specificity of vanadium uptake by AsNramp and rat DCT1 in Xenopus oocytes. Oocytes were 
injected with 30–36 ng of AsNramp (solid bars) or rat DCT1 (gray bars) mRNA per oocyte and 
incubated for 4 days in MBS buffer before the uptake experiment. Control oocytes (open bars) were 
prepared at the same time and incubated in MBS buffer. A) VO2+ uptake was examined in a basal buffer 
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(10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2) supplemented with 100 mM 
sodium chloride (NaCl) or choline chloride (Chol), and at pH 5.5 and 7.5, as indicated, at 20°C. The 
initial VO2+ concentration was 10.5 µM. Bars indicate means ± SD (n = 8). B) VO2+ uptake was 
examined in basal buffer (10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2) 
supplemented with 100 mM choline chloride at 20°C. The initial VO2+ concentration was 10.5 µM. Bars 
indicate means ± SD (n = 5). C) The inhibition of VO2+-uptake by protonophore FCCP. VO2+ uptake was 
examined in basal buffer (10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 5.5 
or 8.5) supplemented with 100 mM choline chloride at 20°C. The initial VO2+ concentration was 10.5 
µM. FCCP was added at 2.5 µM where indicated. Bars indicate means ± SE (n = 12). ***, P<0.001. 
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Fig. 6. The inhibition of VO2+-uptake by AsNramp by excess divalent cations. Oocytes were injected 
with 32 ng of AsNramp mRNA per oocyte and incubated for 4 days before the uptake experiment. VO2+ 
uptake was examined in basal buffer (10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM CaCl2, 1 mM 
MgCl2, pH 8.5) supplemented with 100 mM choline chloride at 20°C. The initial VO2+ concentration 
was 10.5 µM, and the concentration of competitive divalent cations (COMP) were 525 µM (50 molar 
excess). Ascorbic acid (ASC) was added at 2.1 mM (4 molar excess) for control and Fe2+. Bars indicate 
means ± SE (n = 10–12). *, P<0.05; **, P<0.01. 
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Fig. 7. Kinetic properties of vanadium uptake by AsNramp. Vanadium uptake was measured with 
increasing concentrations of VO2+ in uptake buffer (10 mM HEPES, 2 mM MES, 2 mM KCl, 1 mM 
CaCl2, 1 mM MgCl2, pH 8.5) containing 100 mM choline chloride. Each data point represents the mean 
value ± SD (n = 5). Calculated from the data between 0 and 10 µM, the Km and Vmax of AsNramp were 
90 nM and 9.1 pmol/oocyte/h, respectively, under these conditions (dotted lines). 
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Fig. 8. A model for vanadium transport in vanadocytes of the vanadium-rich ascidian Ascidia 
sydneiensis samea. Vanadium ions are transported by an anion transporter (for VV) or cation transporter 
(for VIV) into the cytoplasm of vanadocytes. VV is reduced to VIV through an electron transfer cascade 
from the electron donor, NADPH, via glutathione reductase, glutathione, and Vanabin2 [19]. The 
vacuole content is acidified by V-ATPase, and AsSUL1 accumulates sulfate ions. P1B-type ATPase, 
AsHMA1, and/or a proton/VIV antiporter, AsNramp, transports VIV into the vacuole. VIV is reduced to 
VIII by an as yet unknown reductant and stabilized in acidic solution, in which sulfate ions exist as 
counterions for VIII. Reproduced from [45] with permission from the copyright holders.  
 
